IBSA Partners with Professional Pickleball Player James Ignatowich to Promote Licart Pain Patch

Pickleball, the fastest-growing sport in the U.S., is not only gaining popularity on the court but also in the world of sports marketing. IBSA, the Swiss pharma company, is making a strategic move by teaming up with professional pickleball player James Ignatowich to promote its Licart pain patch.

In a recent announcement, IBSA USA revealed that Ignatowich will be representing the Licart brand during Professional Pickleball Association Tour events throughout the 2024 season. Not only will he be sporting the Licart logo on his clothing, but he will also be acting as the brand’s spokesperson on social media and at Major League Pickleball events. Additionally, IBSA will be sponsoring Ignatowich’s pickleball clinics, further solidifying their partnership.

Ignatowich, a seasoned athlete himself, understands the importance of pain management in optimizing performance on the court. He recognizes that after intense matches or training sessions, muscle soreness can be a common issue for pickleball players. By using topical patches like Licart, players can aid in acute pain recovery from sprains and strains, allowing them to get back on the court faster and stronger.

Licart, an FDA-approved nonsteroidal anti-inflammatory patch, provides 24-hour pain relief for minor strains, sprains, and contusions. With its once-daily application and quick onset of action, Licart offers a convenient and effective solution for managing acute pain. Each box contains 15 patches, meant to be applied directly to the skin over the area of pain.

IBSA’s decision to partner with Ignatowich in the world of pickleball comes after successful collaborations with professional golfers in the past. By recognizing the growing popularity of pickleball and the need for effective pain management solutions in the sport, IBSA is positioning Licart as a reliable option for the pickleball community.

Michael Scully, head of commercial operations for IBSA USA, emphasized the alignment between Licart and the needs of the pickleball community. With its low systemic exposure and minimal adverse events, Licart provides players with a safe and effective way to manage acute pain, allowing them to focus on their game without distractions.

As pickleball continues to soar in popularity, IBSA’s partnership with James Ignatowich highlights the company’s commitment to supporting athletes and providing innovative solutions for pain management. With Licart leading the way, pickleball players can now have a trusted ally in their quest for peak performance on the court.